Ethical challenges in managing unvaccinated patients receiving chronic in-centre haemodialysis.
Gaetano AlfanoFrancesco FontanaNiccolò MorisiGiacomo MoriGianni CappelliRiccardo MagistroniGabriele DonatiPublished in: Clinical kidney journal (2021)
Insufficient vaccine coverage and dominance of the more transmissible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are the leading causes of the continued spread of coronavirus disease 2019 (COVID-19) worldwide. To curb the surge in infections, COVID-19 vaccination has been advocated as a priority measure, especially for frail populations and people at high risk of exposure. Patients on in-centre maintenance haemodialysis (HD) embody both conditions. They are at high risk of severe COVID-19 consequences due to their advanced age and weakened immune system and carry an increased risk of SARS-CoV-2 transmission within shared dialysis rooms and public vehicles. Vaccination of the entire HD population is therefore the most effective strategy to protect patients from the dire consequences of COVID-19. Unfortunately, a minority of patients still express COVID-19 vaccine hesitancy. The management of this group of patients, who have the full right to HD treatment, poses demanding problems from a patient safety perspective. The placement of unvaccinated patients within the dialysis room and the protection of all vaccinated patients are some of the most urgent problems the nephrologist faces during the COVID-19 pandemic. In light of these COVID-19-driven changes, an ethical reflection on the management of unvaccinated patients appears crucial to act responsibly and contribute to the health promotion of dialysis patients.
Keyphrases
- end stage renal disease
- sars cov
- coronavirus disease
- chronic kidney disease
- peritoneal dialysis
- newly diagnosed
- ejection fraction
- respiratory syndrome coronavirus
- patient safety
- prognostic factors
- mental health
- emergency department
- healthcare
- decision making
- health insurance
- health promotion
- electronic health record
- adverse drug
- combination therapy